Evercore ISI's Mark Mahaney likes Meta, but says other names will give more upside
Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell' to discuss the markets, Meta's historic winning ...
CRISPR upped to outperform by Evercore on upcoming data
Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
Evercore ISI Cuts Teradata (NYSE:TDC) Price Target to $32.00
Teradata (NYSE:TDC – Free Report) had its target price cut by Evercore ISI from $37.00 to $32.00 in a research report report ...
Fintel on MSN18h
Evercore ISI Group Upgrades CRISPR Therapeutics (CRSP)
Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...
Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $45.00 at Evercore ISI
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target hoisted by Evercore ISI from $33.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently ...
CRISPR Therapeutics stock rises following analyst upgrade
Evercore ISI analyst Liisa Bayko raised the price target for CRISPR Therapeutics from $60.00 to $99.00. Bayko's optimism is driven by upcoming catalysts that could mark a new chapter for the company.
Crowdfund Insider14h
Bitcoin Mining Firm Riot Platforms Shares Updates Including Formal Evaluation of AI and HPC Uses
Riot Platforms, Inc, an industry participant focused on vertically integrated Bitcoin mining, announced the appointment of ...
secondariesinvestor14h
AlpInvest emerges as lead on Bain Capital’s $2bn CV
Carlyle is wrapping up a two-year fundraising campaign for its eighth secondaries flagship, CEO Harvey Schwartz said on the ...